M&A

Biogen surges on potential buyout deal from South Korea's Samsung Group
Seeking Alpha
Wed, 12/29/21 - 02:34 pm
Biogen
M&A
Sansung Group
Quidel to buy Ortho Clinical Diagnostics in $6B deal
Medtech Dive
Tue, 12/28/21 - 10:59 am
Quidel
M&A
Ortho Clinical Diagnostics
diagnostics
Medtech
GE Healthcare closes $1.45B acquisition of BK Medical
MedCity News
Wed, 12/22/21 - 11:40 pm
GE Healthcare
M&A
BK Medical
ultrasound
devices
Medtech
Medical Imaging
Novartis to acquire Gyroscope Therapeutics, gaining ocular gene therapy
Biopharma Reporter
Wed, 12/22/21 - 11:16 am
Novartis
Gyroscope Therapeutics
ocular gene therapy
gene therapy
M&A
Sanofi buys US immuno-oncology biotech Amunix for $1 billion
Pharmaforum
Tue, 12/21/21 - 10:36 am
Sanofi
M&A
Amunix
immuno-oncology
cancer
solid tumors
oncology
IACT LMC Manna Research Merges with True North Clinical Research, Boosting the Network’s Central Nervous System Disorder Capabilities
CP WIre
Mon, 12/20/21 - 12:30 pm
IACT Health
True North Clinical Research
R&D
M&A
IACT LMC Manna Research
CNS
Days after buyout news, Vifor outlines plan to offload 'non-core' finished drug manufacturing wing
Endpoints
Thu, 12/16/21 - 11:53 pm
Vifor Pharma
CSL
M&A
Biopharma’s buyout year ends with a bang
EP Vantage
Wed, 12/15/21 - 10:37 am
M&A
CSL
Vifor Pharma
Pfizer
Arena Pharmaceuticals
Tidy up your labs, biotech. Pfizer is coming with 'significant firepower' and cash to burn
Fierce Biotech
Tue, 12/14/21 - 11:08 am
Pfizer
biotech
M&A
Arena Pharmaceuticals
Bristol Myers Squibb, after massive Celgene takeover, plots $15B buyback plan
Fierce Pharma
Tue, 12/14/21 - 10:43 am
Bristol Myers Squibb
Celgene
M&A
stock buybacks
Arena, completing its turnaround, sells to Pfizer for nearly $7 billion
BioPharma Dive
Mon, 12/13/21 - 11:08 am
Pfizer
M&A
Arena Pharmaceuticals
inflammation
etrasimod
As year-end deals start to sizzle, CSL moves a biotech buyout to the front burner with deal expected Tuesday — report
Endpoints
Mon, 12/13/21 - 11:02 am
M&A
Vifor Pharma
CSL
AstraZeneca blocks investor group's $7.6B buyout of rare disease specialist Sobi: report
Fierce Pharma
Fri, 12/3/21 - 10:45 am
AstraZeneca
Alexion
Sobi
M&A
Get ready for M&A: Large biopharma companies will have $1.7T in dealmaking firepower next year, analyst says
Fierce Pharma
Wed, 12/1/21 - 11:28 am
M&A
pharma industry
Big Pharma
JNJ
Pfizer
Moderna Therapeutics
Novartis
BioNTech
GSK
Sanofi to buy Origimm Biotechnology for acne vaccine candidate
Reuters
Wed, 12/1/21 - 10:13 am
Sanofi
Origimm Biotechnology
M&A
vaccines
acne
Riding success of Roche-partnered lung cancer drug, Blueprint makes $250M play for Lengo's preclinical work
Fierce Biotech
Mon, 11/29/21 - 11:07 am
Blueprint Medicines
M&A
Lengo Therapeutics
Sun Pharma loses bid to drop Ranbaxy antitrust case; jury trail set for January
Fierce Pharma
Fri, 11/26/21 - 08:46 pm
Sun Pharma
Ranbaxy
M&A
antitrust
Sanifit, having put Spain's biotech scene on the map, lands $231M Vifor buyout ahead of phase 3 data
Fierce Biotech
Mon, 11/22/21 - 10:23 am
Spain
Sanifit
M&A
Vifor Pharma
EQT, Biontech investor family consider Sandoz bid
Yahoo/Reuters
Fri, 11/19/21 - 11:12 am
EQT
BioNTech
Sandoz
generics
Novartis
M&A
Novo Nordisk bets big on RNAi, paying $3.3B to buy Dicerna
Fierce Biotech
Thu, 11/18/21 - 10:54 am
Novo Nordisk
M&A
Dicerna Pharmaceuticals
RNAi

Pages